China Pharma Holdings, Inc.
CPHI
$0.65
-$0.01-1.39%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 62.13% | -26.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 62.13% | -26.28% | |||
| Cost of Revenue | 31.78% | -26.68% | |||
| Gross Profit | 352.60% | 31.38% | |||
| SG&A Expenses | 119.78% | -2.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 75.28% | -9.38% | |||
| Operating Income | -91.13% | -25.19% | |||
| Income Before Tax | -87.58% | -23.30% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -87.58% | -23.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -87.58% | -23.30% | |||
| EBIT | -91.13% | -25.19% | |||
| EBITDA | -158.48% | -50.44% | |||
| EPS Basic | -7.49% | -3.83% | |||
| Normalized Basic EPS | -7.52% | -3.85% | |||
| EPS Diluted | -7.49% | -3.83% | |||
| Normalized Diluted EPS | -7.52% | -3.85% | |||
| Average Basic Shares Outstanding | 74.52% | 18.76% | |||
| Average Diluted Shares Outstanding | 74.52% | 18.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||